Get started
Author

Rafael Luque Márquez

Observed names: Luque Márquez Rafael, R Luque Marquez, R Luque Márquez, R Luque-Márquez, R. Luque Márquez, R. Luque-Márquez, R. Luque‐Marquez, Rafael Luque-Marquez, Rafael Luque-Márquez, Rafael Luquez Marquez, Rafael Luque‐Márquez
Observed institutions: Universitat Autònoma de Barcelona, Consejo Superior de Investigaciones Científicas, Andalusian Health Service, Instituto de Salud Carlos III, Hospital Universitario Virgen Macarena, Vall d'Hebron Institut de Recerca, Hospital Clínic de Barcelona, Vall d'Hebron Hospital Universitari, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío, Hospital Clínico Universitario Virgen de la Victoria, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Centro de Investigación Biomédica en Red Enfermedades Infecciosas, Universitat de Barcelona, Universidad de Sevilla
ORCID: 0000-0002-7563-5815
Observed ORCID: 0000-0002-7563-5815
OpenAlex ID: A5037273636
Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
2021 · Alberto Pérez-Gómez, Joana Vitallé, et al. · Cellular and Molecular Immunology · 124
PDF
Treatment of Enterococcus faecalis Infective Endocarditis: A Continuing Challenge
2023 · Laura Herrero-Hidalgo, Beatriz Fernández-Rubio, et al. · Antibiotics · 72
PDF
Stability of Antimicrobials in Elastomeric Pumps: A Systematic Review
2021 · Beatriz Fernández-Rubio, Paula del Valle-Moreno, et al. · Antibiotics · 37
SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome
2021 · Sonsoles Salto-Alejandre, Judith Berastegui-Cabrera, et al. · Scientific Reports · 32
Enterococcus faecalis Endocarditis and Outpatient Treatment: A Systematic Review of Current Alternatives
2020 · Laura Herrera-Hidalgo, Arístides de Alarcón, et al. · Antibiotics · 30
PDF
Epidemiology and Risk Factors of Mycotic Aneurysm in Patients With Infective Endocarditis and the Impact of its Rupture in Outcomes. Analysis of a National Prospective Cohort
2024 · Jorge Calderón-Parra, Fernando Domínguez, et al. · Open Forum Infectious Diseases · 27
Outpatient parenteral antimicrobial therapy in Enterococcus faecalis infective endocarditis
2017 · M. V. Gil‐Navarro, L. E. Lopez‐Cortes, et al. · Journal of Clinical Pharmacy and Therapeutics · 26
PDF
Ceftriaxone pharmacokinetics by a sensitive and simple LC–MS/MS method: Development and application
2020 · L. Herrera-Hidalgo, M.V. Gil-Navarro, et al. · Journal of Pharmaceutical and Biomedical Analysis · 23
Continuous versus intermittent piperacillin/tazobactam infusion in infection due to or suspected pseudomonas aeruginosa
2015 · Jesús Cotrina-Luque, Maria Victoria Gil-Navarro, et al. · International Journal of Clinical Pharmacy · 23
Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial Therapy
2020 · L. Herrera-Hidalgo, L. E. López-Cortes, et al. · Antimicrobial Agents and Chemotherapy · 22
Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT
2021 · Laura Herrera-Hidalgo, Jose Manuel Lomas-Cabezas, et al. · Journal of Clinical Medicine · 21
Blood culture-negative infective endocarditis: a worse outcome? Results from a large multicentre retrospective Spanish cohort study
2021 · Lorenzo Roberto Suardi, Arístides de Alarcón, et al. · Scandinavian Journal of Infectious Diseases · 21
Left-sided infective endocarditis in patients with liver cirrhosis
2015 · J. Ruiz-Morales, R. Ivanova-Georgieva, et al. · Journal of Infection · 20
Tunneled Hemodialysis Catheter-Related Bloodstream Infections: A Prospective Multicenter Cohort Study from Spain
2012 · Almudena Martín-Peña, Rafael Luque Márquez, et al. · The Journal of Vascular Access · 20
Stability Studies of Antipseudomonal Beta Lactam Agents for Outpatient Therapy
2023 · Beatriz Fernández-Rubio, Laura Herrera-Hidalgo, et al. · Pharmaceutics · 19
PDF
Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis
2020 · Laura Escolà-Vergé, Guillermo Cuervo, et al. · Clinical Microbiology and Infection · 17
Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs?
2020 · Laura Herrera-Hidalgo, Arístides de Alarcón, et al. · Antimicrobial Agents and Chemotherapy · 15
Antifungal treatment administered in OPAT programs is a safe and effective option in selected patients
2020 · Maria Victoria Gil-Navarro, Rafael Luque-Marquez, et al. · Enfermedades Infecciosas y Microbiología Clínica · 15
Mural Endocarditis: The GAMES Registry Series and Review of the Literature
2021 · Andrea Gutiérrez-Villanueva, Patricia Muñoz, et al. · Infectious Diseases and Therapy · 14
PDF
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
2023 · Laura Herrera-Hidalgo, Patricia Muñoz, et al. · International Journal of Infectious Diseases · 12
PDF
Non-nosocomial Healthcare-Associated Infective Endocarditis: A Distinct Entity? Data From the GAMES Series (2008–2021)
2023 · David Alonso-Menchén, Emilio Bouza, et al. · Open Forum Infectious Diseases · 12
PDF
Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy
2023 · Beatriz Fernández-Rubio, Laura Herrera-Hidalgo, et al. · Antibiotics · 12
PDF
Impact of Intermediate Susceptibility to Penicillin on Antimicrobial Treatment and Outcomes of Endocarditis Caused by Viridans and Gallolyticus Group Streptococci
2023 · Francesc Escrihuela-Vidal, Damaris Berbel, et al. · Clinical Infectious Diseases · 11
Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT
2022 · Laura Herrera-Hidalgo, Rafael Luque-Márquez, et al. · Journal of Clinical Medicine · 9
Hospital Pharmacy in the multidisciplinary team of COVID inpatient units.
2020 · María Victoria Gil-Navarro, Rafael Luque-Márquez · PubMed · 9
Works count: 85
Citation count: 756
H-index: 16
I10-index: 24
Year
Topic
Type